Industry Insights

Industry Insights

Real-world data in EAPs: makes sense for rare diseases

By CONTRIBUTOR

13 November 2024

Industry Insights

Putting patients first?

By CONTRIBUTOR

2 October 2024

Industry Insights

NICE’s key developments in 2024 in summary

By CONTRIBUTOR

11 September 2024

Industry Insights

How ‘do’ we versus how ‘should’ we think about disease awareness activities?

By CONTRIBUTOR

30 August 2024

Industry Insights

Cell and gene therapies: Where are we now?

By CONTRIBUTOR

31 July 2024

Industry Insights

Early access to medicines: A picture is worth a thousand words

By CONTRIBUTOR

17 July 2024

Industry Insights

What can rare disease services learn from oncology services? A personal reflection

By CONTRIBUTOR

1 July 2024

Industry Insights

What are the next steps for rare disease innovation in the United Kingdom?

By CONTRIBUTOR

15 May 2024

Industry Insights

As we enter a new financial year, how does the UK Budget affect the rare disease community?

By CONTRIBUTOR

10 April 2024

Industry Insights

Living well today: How do we make it happen for the rare diseases community?

By CONTRIBUTOR

13 March 2024

Industry Insights

Rare Disease Day 2024: Sheela Upadhyaya previews some of the events taking place across the world

By CONTRIBUTOR

14 February 2024

Industry Insights

The UK Rare Diseases Framework: Sheela Upadhyaya reflects on recent progress across the UK

By CONTRIBUTOR

12 February 2024

Industry Insights

UK report calls for more government input to make cell and gene therapies a true health system priority

By CONTRIBUTOR

9 January 2024

Industry Insights

Together4RD: making ERN-industry collaboration a key pillar of the future in the rare disease research ecosystem

By CONTRIBUTOR

11 October 2023

Industry Insights

Living well with a rare disease: are we really supporting our community to achieve this?

By CONTRIBUTOR

25 September 2023

Industry Insights

The ABPI Code Partnership events: a step towards better partnerships?

By CONTRIBUTOR

12 July 2023

Industry Insights

COVID: Three years on—what has changed?

By CONTRIBUTOR

3 May 2023

1 2 Next »